Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual-Engine Growth
21 déc. 2023 21h16 HE
|
Polaris Group
TAIPEI, Taiwan and SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Polaris Group (The Company, TWSE:6550) announced that its board approved to increase the acquisition of Genovior Biotech's shares to...
Rentschler Biopharma Announces Major Client Project for New U.S. Facility at Milford, MA Site
20 déc. 2023 07h00 HE
|
Rentschler Biopharma SE
State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year LAUPHEIM, Germany and MILFORD, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Rentschler...
Intravacc launches new website with a wealth of scientific knowledge to elevate vaccine innovation
20 déc. 2023 06h10 HE
|
Intravacc B.V.
Intravacc's new website offers an immersive user experience, showcasing their CDMO expertise vaccine platforms and a hub for scientific publications.
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
07 déc. 2023 16h05 HE
|
Avid Bioservices, Inc
-- Recorded Second Quarter Revenue of $25.4 Million -- -- Signed $35 Million in Net New Business Orders Resulting in a Backlog of $199 Million -- -- Entered into Partnership with California...
Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board
07 déc. 2023 04h00 HE
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO)...
Global Recombinant Protein Therapeutics CDMO Market Report 2023-2030: Market Set to Grow Driven by Rising Chronic Diseases, Advancements in Biotechnology Fuel Demand
06 déc. 2023 09h53 HE
|
Research and Markets
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines,...
Asia-Pacific Nucleic Acid Therapeutics CDMO Market Report 2023: Market to Reach $4.04 Billion by 2033 - Significant Number of Collaborations among Market Players
06 déc. 2023 04h58 HE
|
Research and Markets
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Asia-Pacific Nucleic Acid Therapeutics CDMO Market - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The...
Global Biologics CDMO Market Research Report 2023-2033: Biologics Revolutionizes Treatments, Complex Biologic Molecules Drive Demand for CDMO Services
06 déc. 2023 03h23 HE
|
Research and Markets
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Biologics CDMO Market - A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The global...
SOHM Announces Business Outlook for 2024
05 déc. 2023 09h30 HE
|
SOHM, Inc.
CHINO HILLS, Calif., Dec. 05, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical and cosmeceutical Company that manufactures and markets...
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
30 nov. 2023 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...